MARC details
| 000 -LEADER |
| fixed length control field |
04591cam a22004574a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20250919000621.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
140915s2010 enka bf 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780521136723 (pbk.) |
| Terms of availability |
RM247.47 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0521136725 (pbk.) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
| Level of rules in bibliographic description |
201409261124 |
| Level of effort used to assign nonsubject heading access points |
zainol |
| y |
09-15-2014 |
| z |
fida |
| 040 ## - CATALOGING SOURCE |
| Modifying agency |
UKM |
| Description conventions |
rfa |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV39.S587e 2010 9 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV39 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) |
.S587e 2010 9 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Silberstein, Stephen D. |
| Relator term |
author |
| 245 10 - TITLE STATEMENT |
| Title |
Essential neuropharmacology : |
| Remainder of title |
the prescriber's guide / |
| Statement of responsibility, etc. |
Stephen Silberstein, Michael Marmura ; edited by Stephen M. Stahl ; with illustrations by Nancy Muntner. |
| 246 13 - VARYING FORM OF TITLE |
| Title proper/short title |
Prescriber's guide |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
Cambridge : |
| Name of producer, publisher, distributor, manufacturer |
Cambridge University Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2010. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xv, 403 p. : |
| Other physical details |
illustration ; |
| Dimensions |
23 cm. |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
| Series statement |
Cambridge medicine |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Acetozolamide -- Almotriptan -- Alteplase -- Amantadine -- Amitriptyline -- Apomorphine -- Armodafinil -- Aspirine (acetylsalicylic acid) -- Azathioprine -- Baclofen -- Benztropine -- Botulinum Toxin A -- Botulinum Toxin B -- Bromocriptine -- Carbamezapine -- Carbidopa/Levidopa -- Carisoprodol -- Chlorpromazine -- Clonazepam -- Clonidine -- Clopidogrel -- Clozapine -- Cyclobenzaprine -- Cyclophosphamide -- Cyclosporine -- Cyproheptadine -- Dantrolene -- 3,4 diaminopyrimidine -- Diazepam -- Dihydroergotamine -- Dipyridamole and aspirin -- Donepezil -- Droperidol -- Duloxetine -- Edrophonium -- Eletriptan -- Entacapone -- Ethosuximide -- Felbamate -- Flunarizine -- Fluoxetine -- Frovatriptan -- Gabapentin -- Galantamine -- Glatiramer acetate -- Guanfacine -- Guanidine hydrochloride -- Haloperidol -- Heparin -- Immune globulin intravenous (IGIV) -- Indomethacin -- Interferon-beta -- Lacosamide -- Lamotrigine -- Levetiracetam -- Lithium -- Mannitol -- Meclizine -- Memantine -- Metaxalone -- Methocarbamol -- Methotrexate -- Methylergonovine -- Methysergide -- Metoclopramide -- Mexiletine -- Mitoxantrone -- Modafinil -- Mycophenolate mofetil -- Naratriptan -- Natalizumab -- Nimodipine -- Nortriptyline -- Oxcarbazepine -- Penicilamine -- Phenobarbital -- Phenytoin -- Pizotifen -- Pramipexole -- Prednisone -- Pregabalin -- Primidone -- Prochlorperazine -- Propranolol -- Pyridostigmine -- Quetiapine -- Quinine sulfate -- Rasagiline -- Reserpine -- Riluzole -- Rituximab -- Rivastigmine -- Rizatriptan -- Ropinirole -- Rufinamide -- Selegiline -- Sumatriptan -- Tetrabenazine -- Tiagabine -- Timolol -- Tizanidine -- Topiramate -- Trientine hydrochloride -- Trihexyphenidyl -- Valproic acid -- Venlafaxine -- Verapamil -- Vigabatrin -- Warfarin -- Zolmitriptan -- Zonisamide. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
'Essential Neuropharmacology: The Prescriber's Guide expertly reviews the most important medications used by neurologists in their practice. Experienced clinicians share their expert knowledge about the best use of medications in patient care. Each drug listing contains the range of indications, their advantages and disadvantages, and tips for dosing and avoiding adverse effects. Experts in fields such as multiple sclerosis, movement disorders, neuromuscular disorders, epilepsy, stroke, pain and headache summarize how neurologists use these medications to their best effect, and discuss off-label uses in neurology. Evidence is taken from recent clinical trials, which helps the reader relate the content to everyday clinical practice. The detailed descriptions of each medication enable the user to make quick and informed decisions with the confidence they need to best serve the clinical needs of their patients. This book is an essential, user-friendly reference suitable for all neurologists at all stages of their careers'--Provided by publisher. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Central Nervous System Agents |
| General subdivision |
pharmacology |
| Form subdivision |
Handbooks. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Central Nervous System Agents |
| General subdivision |
therapeutic use |
| Form subdivision |
Handbooks. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Central Nervous System Diseases |
| General subdivision |
drug therapy |
| Form subdivision |
Handbooks. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Neuropharmacology. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01036458 |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Handbooks, manuals, etc. |
| Source of term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01423877 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Marmura, Michael James. |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Stahl, Stephen M., |
| Dates associated with a name |
1951- |
| Relator term |
editor |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Cambridge medicine (Series) |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
| a |
.b15989550 |
| b |
2019-11-12 |
| c |
2019-11-12 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Koha item type |
AM |
| Suppress in OPAC |
No |
| Call number prefix |
QV39.S587e 2010 9 |
| 914 ## - VTLS Number |
| VTLS Number |
vtls003569195 |
| 990 ## - EQUIVALENCES OR CROSS-REFERENCES [LOCAL, CANADA] |
| Link information for 9XX fields |
zr |
| 991 ## - LOCAL NOTE (NAMA FAKULTI/INSTITUT/PUSAT) |
| a |
Fakulti Farmasi, KKL |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
| Library |
PERPUSTAKAAN DR ABDUL LATIFF |
| Operator's initials, OID (RLIN) |
2014-02-09 |
| Cataloger's initials, CIN (RLIN) |
m |
| Material Type (Sierra) |
Printed Books |
| Language |
English |
| Country |
|
| -- |
0 |
| -- |
.b15989550 |